Approval · Notice of Compliance 33872 · 2024
TEVA-NABILONE: Notice of Compliance 33872
Issued August 26, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33872
- Date
- August 26, 2024
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Update to package labels
- Canadian reference product
- CESAMET
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TEVA-NABILONE | Not yet assigned | — |